FindTrial
Sign In

Comparison of contrast enhanced ultrasonography (CEUS) to conventional sonography for transrectal ultrasound guided prostate biopsies

Comparison of contrast enhanced ultrasonography (CEUS) to conventional sonography for transrectal ultrasound guided prostate biopsies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN08205352
Enrollment
Unknown
Registered
2006-09-29
Start date
2005-08-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Prostate Cancer Prostate

Interventions

Randomised controlled trial

Sponsors

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: All men whose plasma PSA levels warrant prostate biopsies.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
The clinician performing the prostate biopsies will define the 10 biopsied areas as normal or abnormal. This classification will then be compared to the final pathological examination of the biopsy and the sensitivity and specificity of each move of sonography will be calculated.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026